Department of Optometry, the College of Applied Medical Science, Qassim University, Qassim, Saudi Arabia; School of Optometry & Vision Science, University of New South Wales, Sydney, Australia; Brien Holden Vision Institute, Sydney, Australia.
School of Optometry & Vision Science, University of New South Wales, Sydney, Australia.
Cont Lens Anterior Eye. 2020 Apr;43(2):154-158. doi: 10.1016/j.clae.2019.07.007. Epub 2019 Aug 6.
To investigate the association between levels of MMP-9, a common marker of inflammation in tears, and changes to the meibomian glands accompanying soft contact lens (CL) wear.
Flush tears were collected from: (1) three groups of CL wearers who had worn CLs on a daily basis for different durations (Short: 2 ± 1 years, Moderate: 5 ± 1 years and Long experience: 10 ± 2 years); (2) a group of previous CL wearers (PWs) who had ceased wear for at least 6 months; and (3) healthy non-wearers (NW) as a control group. Total MMP-9 and its inhibitor, tissue inhibitor of MMPs-1 (TIMP-1) concentration were established using sandwich enzyme-linked immunosorbent assay. The MMP-9: TIMP-1 ratio was calculated for every individual, and then the average of all ratios for each group were compared. The non-parametric statistical Kruskal Wallis one-way analysis of variance was used for comparison, with Dunn's testing post-hoc.
Tear samples from 100 participants (51 females; mean age ± SD: 25.4 ± 4.1 years) were analysed. MMP-9 concentrations and MMP-9:TIMP-1 ratio were significantly different between groups (Kruskal Wallis p = 0.001 and p < 0.001 respectively), while the concentration of TIMP-1 did not vary statistically between study groups (Kruskal Wallis, p = 0.32). Post hoc analysis indicated that only CL wearers with short experience had MMP-9 concentrations that were significantly high compared to NWs (23.1 ± 17.9 ng/mL and 4.1 ± 4.1 ng/mL, respectively, Dunn p < 0.001). Additionally, the ratio of MMP-9 to TIMP-1 concentration was only significantly greater in CL wearers with short experience (mean ratio ± SD = 1.15 ± 0.76) when compared to NWs (0.19 ± 0.29, Dunn P < 0.001), CL wearers with moderate experience (0.37 ± 0.41; P = 0.01) and PWs (0.38 ± 0.36; P = 0.02).
The early years of CL wear appear to be associated with increased expression of MMP-9 relative to its inhibitor TIMP-1. This may be indicative of low-level inflammation during this phase of wear. The role this plays in propagating dry eye disease and MGD in CL wear requires further exploration.
研究眼泪中常见炎症标志物基质金属蛋白酶 9(MMP-9)水平的变化与软性隐形眼镜(CL)佩戴引起的睑板腺变化之间的关系。
从三组不同佩戴时间的 CL 佩戴者(短:2±1 年,中:5±1 年,长:10±2 年)、一组以前的 CL 佩戴者(PW)和健康非佩戴者(NW)中收集冲洗眼泪:(1)连续佩戴 CL 的时间;(2)至少停止佩戴 6 个月;(3)。使用夹心酶联免疫吸附测定法确定总 MMP-9 及其抑制剂基质金属蛋白酶抑制剂 1(TIMP-1)浓度。计算每个人的 MMP-9:TIMP-1 比值,然后比较每组的平均比值。采用非参数统计 Kruskal Wallis 单向方差分析进行比较,采用 Dunn 事后检验。
分析了 100 名参与者(51 名女性;平均年龄±标准差:25.4±4.1 岁)的泪液样本。组间 MMP-9 浓度和 MMP-9:TIMP-1 比值差异有统计学意义(Kruskal Wallis p=0.001 和 p<0.001),而研究组间 TIMP-1 浓度无统计学差异(Kruskal Wallis,p=0.32)。事后分析表明,只有短时间佩戴 CL 的佩戴者 MMP-9 浓度明显高于 NW(分别为 23.1±17.9ng/mL 和 4.1±4.1ng/mL,Dunn p<0.001)。此外,只有短时间佩戴 CL 的佩戴者 MMP-9 与 TIMP-1 浓度的比值明显大于 NW(平均比值±标准差=1.15±0.76)(0.19±0.29,Dunn P<0.001)、中度经验佩戴者(0.37±0.41;P=0.01)和 PW(0.38±0.36;P=0.02)。
CL 佩戴的早期阶段,MMP-9 的表达相对于其抑制剂 TIMP-1 增加。这可能表明在这一佩戴阶段存在低度炎症。CL 佩戴者中,这种情况在传播干眼症和 MGD 中的作用需要进一步探讨。